Comparative Efficacy of Intravenous Ketamine and Tramadol in Reducing Postspinal Anesthesia Shivering in Urological Surgeries: A Triple-blind Randomized Clinical Trial
Authors:
Open Access
- 1 July 2024
- journal article
- Published by Wolters Kluwer Health in Journal of Research in Pharmacy Practice
- Vol. 13 (3) , 92-99
Abstract
Objective: Shivering is one of the most common complications due to disturbances in the thermoregulatory system after regional anesthesia, leading to adverse outcomes and decreased patient satisfaction. Ketamine and tramadol are considered mild analgesics that affect the thermoregulatory center. This triple-blind, randomized clinical trial aims to explore the comparative efficacy of intravenous ketamine and tramadol in reducing postspinal anesthesia shivering in high-risk urological surgeries. Methods: A total of 90 patients undergoing urological surgeries under spinal anesthesia at Shahid Hasheminejad Hospital in Tehran in 2024 were randomized into three groups: ketamine (0.5 mg/kg), tramadol (0.5 mg/kg), and placebo (normal saline). Variables, including ambient temperature, patient demographics, surgery duration, and anesthetic techniques, were meticulously controlled. The primary outcome was the incidence of shivering, measured using the Crossley and Mahajan scale. Data were analyzed using the SPSS software Version 19, employing Chi-square tests, analysis of variance, and logistic regression. Findings: The patients were homogeneous regarding demographic and surgical variables. No significant difference was found in patients’ body temperature upon admission. The incidence of shivering was significantly lower in the tramadol group (23.3%) compared to the ketamine group (36.7%) and placebo group (60%) (P = 0.013). Tramadol demonstrated superior efficacy with minimal side effects. Logistic regression analysis confirmed that patients in the tramadol group were significantly less likely to experience shivering (odds ratio = 0.286; 95% confidence interval: 0.098–0.834, P = 0.022). Ketamine, while effective, had a higher incidence of hemodynamic fluctuations and psychotropic effects. Conclusion: The incidence of shivering was significantly lower in the tramadol group compared to the ketamine and placebo groups. Tramadol demonstrated superior efficacy with minimal side effects. While effective, ketamine had a higher incidence of hemodynamic fluctuations and psychotropic effects.Keywords
This publication has 25 references indexed in Scilit:
- Non-pharmacological treatments for shivering post neuraxial anaesthesia for caesarean section: a scoping reviewContemporary Nurse, 2024
- Tramadol poisoning and its management and complications: a scoping reviewAnnals of Medicine & Surgery, 2023
- The clinical toxicology of ketamineClinical Toxicology, 2023
- Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysisJournal of Affective Disorders, 2023
- The effect of ketamine versus tramadol on prophylactic post-spinal shivering in those patients undergoing orthopedic surgery: a prospective cohort study design, 2020BMC Anesthesiology, 2022
- Preventive Effect of Intraoperative Dexmedetomedine, Ketamine, Magnesium Sulfate on Perioperative Shivering Related to Transuretheral Resection of the Prostate [TURB]; A randomized Controlled StudyInternational Journal of Medical Arts, 2022
- Effects of irrigation fluid temperature during flexible ureteroscopic holmium laser lithotripsy on postoperative fever and shivering: a randomized controlled trialBMC Urology, 2021
- Clinical effects of low-dose intravenous ketamine in obstetrics: a systematic reviewAnnals of Critical Care, 2020
- A comparison of the effect of dexamethasone and pethidine for prevention of shivering after spinal anesthesia in caesarean section: randomization clinical trialBiomedical Research and Therapy, 2018
- Efficacy of intravenous tramadol and low-dose ketamine in the prevention of post-spinal anesthesia shivering following cesarean section: a double-blinded, randomized control trialInternational Journal of Women's Health, 2017